Introduction
Non-randomised studies have reported a prognostic advantage with percutaneous coronary intervention (PCI) in the treatment of chronic total occlusions (CTO). Failure to cross and successfully open a CTO confers a worse clinical outcome, however most trials have included occlusions of short duration (7-30 days). PCI success rates are inversely related to the age of vessel occlusion reflecting temporal, cellular changes within a CTO, namely progressive collagen deposition.
Purpose
To assess the medium-term cardiac outcomes of PCI in the treatment of true CTO (endorsed by an expert consensus panel, requiring Thrombolysis In Myocardial Infarction [TIMI] flow grade 0 on angiography and ≥12 weeks duration) using quantitative cardiac magnetic resonance (CMR) imaging.
Methods
23 patents (mean age 60 ± 11, 82% male) referred for PCI to a single vessel de novo CTO underwent CMR examination within one week prior to and 6 months after their procedure. PCI success was defined as recanalisation of the occluded vessel and stent implantation with a final residual diameter stenosis <30%. Left ventricular (LV) function and transmural extent of infarction (TEI) were assessed using standard SSFP and T1-weighted imaging on a 1.5 T MRI system. LV volumes and mass were quantified using a dedicated software package (QMass). Segmental wall thickening (SWT) was calculated by (end systolicend-diastolic wall thickness)/end-diastolic wall thickness × 100%. Myocardial segments were considered dysfunctional if SWT was ≤45%. Viable segments included dysfunctional myocardium with TEI <25%.
Results
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Conclusion
In this single-centre pilot study failed revascularisation of true CTOs was not associated with worse cardiac outcomes compared to successful PCI. Despite a lack of improvement in global systolic function opening a CTO improved SWT within dysfunctional but viable segments. Larger, randomised studies are required to assess the longterm benefits and morbidity of PCI in the treatment of CTOs. 
Success (S) Failed (F) S vs F
P r e P o s t P P r e P o s t P P EF/% 56 ± 8.9 57 ± 7.6 0.64 57.5 ± 8.8 57.0 ± 6.9 0.76 0.22 LVEDI 62.8 ± 12.2 63.8 ± 14.4 0.61 59.9 ± 9.9 61.4 ± 10.7 0.59 0.89 LVESI 28.4 ± 8.8 27.6 ± 8.8 0.52 25.6 ± 6.86 26.3 ± 6.4 0,68 0.46 Infarct size/g 7.0 ± 5.3 8.7 ± 6.1 0.17 8.0 ± 6.2 10.9 ± 6.8 0.17 0.14 Infarct size/% 9.0 ± 5.9 12.0 ± 7.6 0.19 10.0 ± 7.7 13.3 ± 8.2 0.14 0. 
